- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 491/18 - Bridged systems
Patent holdings for IPC class C07D 491/18
Total number of patents in this class: 271
10-year publication summary
|
21
|
20
|
14
|
16
|
20
|
18
|
25
|
29
|
12
|
8
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme LLC | 3735 |
11 |
| Novartis AG | 10263 |
7 |
| Pfizer Inc. | 3384 |
6 |
| The Trustees of Columbia University in the City of New York | 3643 |
5 |
| Nippon Chemiphar Co., Ltd. | 226 |
5 |
| Takeda Pharmaceutical Company Limited | 2715 |
4 |
| Case Western Reserve University | 1888 |
4 |
| Hangzhou Bensheng Pharmaceutical Co., Ltd. | 16 |
4 |
| Revolution Medicines, Inc. | 329 |
4 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 870 |
4 |
| TP Therapeutics, Inc., AKA Turning Point Therapeutics | 9 |
4 |
| Wuhan Institute of Virology, Chinese Academy of Sciences | 51 |
4 |
| Merck Patent GmbH | 5725 |
3 |
| AM Chemicals LLC | 11 |
3 |
| Arkema France | 4238 |
3 |
| Biotelliga Holdings Limited | 11 |
3 |
| Mirati Therapeutics, Inc. | 286 |
3 |
| The Walter and Eliza Hall Institute of Medical Research | 166 |
3 |
| MSD R & D (China) Co. LTD. | 56 |
3 |
| Janssen Sciences Ireland Unlimited Company | 375 |
3 |
| Other owners | 185 |